ReviewClinical reviews in allergy & immunology2011
Recent concepts of autoimmune pancreatitis and IgG4-related disease.
Review in Clinical reviews in allergy & immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed.
- Multifocal autoimmune pancreatitis complicated by pancreatic insufficiency and segmental portal hypertension: A case report and review of the literature.Radiology case reports · 2026Article
- Article
- Complemental Diagnosis of IgG4-Related Pancreaticobiliary Diseases by Multiple Hypoechoic Lesions in the Submandibular Glands.Journal of clinical medicine · 2022Article
- Clinical Usefulness of Serum Autotaxin for Early Prediction of Relapse in Male Patients with Type 1 Autoimmune Pancreatitis.Digestive diseases and sciences · 2021Article
- IgG4-Related Sclerosing Cholangitis: Rarely Diagnosed, but not a Rare Disease.Canadian journal of gastroenterology & hepatology · 2021Review
- Morphologic Cross-Sectional Imaging Features of IgG4-Related Orbitopathy in Comparison to Ocular Adnexal Lymphoma.Clinical ophthalmology (Auckland, N.Z.) · 2021Article
- T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?Frontiers in oncology · 2020Review
- Immunoglobulin G4-related sclerosing cholangitis.The Korean journal of internal medicine · 2018Review
- Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study.Scientific reports · 2018Article
- [Pathogenesis of immunoglobulin G4-related hepatobiliary disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2018Article
- Basophils activated via TLR signaling may contribute to pathophysiology of type 1 autoimmune pancreatitis.Journal of gastroenterology · 2018Article
- Article
- Clinical significance of hypoechoic submandibular gland lesions in type 1 autoimmune pancreatitis.World journal of gastroenterology · 2017Article
- Elevated serum IgG4 levels in diagnosis and treatment response in patients with idiopathic retroperitoneal fibrosis.Clinical rheumatology · 2017Article
- Adult reference intervals for IgG subclasses with Siemens immunonephelometric assays in Chinese population.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2017Article
- Autoimmune pancreatitis as a component of autoimmune polyglandular syndrome.Przeglad gastroenterologiczny · 2017Article
- Long-term outcomes of autoimmune pancreatitis.World journal of gastroenterology · 2016Review
- Characterization and Comparison of Patient Subgroups Suspicious for IgG4-Related Disease and Malignant Lymphoma in Patients Followed-up for Sjögren's Syndrome.Pathology oncology research : POR · 2016Article
- Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma.Journal of clinical gastroenterology · 2016Article
- Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease.BMC musculoskeletal disorders · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent studies suggested the existence of two subtypes of autoimmune pancreatitis (AIP): type 1 related with IgG4 (lymphoplasmacytic sclerosing pancreatitis; LPSP) and type 2 related with a granulocytic epithelial lesion (idiopathic duct-centric chronic pancreatitis; IDCP). Apart from type 2 AIP, the pathological features of type 1 AIP with increased serum IgG4/IgE levels, abundant infiltration of IgG4+ plasmacytes and lymphocytes, fibrosis, and steroid responsiveness are suggestive of abnormal immunity such as allergy or autoimmunity. Moreover, the patients with type 1 AIP often have extrapancreatic lesions such as sclerosing cholangitis, sclerosing sialadenitis, or retroperitoneal fibrosis showing similar pathological features. Based on these findings, many synonyms have been proposed for these conditions, such as "multifocal idiopathic fibrosclerosis", "IgG4-related autoimmune disease", "IgG4-related sclerosing disease", "IgG4-related plasmacytic disease", and "IgG4-related multiorgan lymphoproliferative syndrome", all of which may refer to the same conditions. Therefore, the Japanese Research Committee for "Systemic IgG4-related Sclerosing Disease" proposed a disease concept and clinical diagnostic criteria based on the concept of multifocal fibrosclerosis in 2009, in which the term "IgG4-related disease" was appointed as a minimal consensus on these conditions. Although the significance of IgG4 in the development of "IgG4-related disease" remains unclear, we have proposed a hypothesis for the development of type 1 AIP, one of the IgG4-related disease. The concept and diagnostic criteria of "IgG4-related disease" will be changed in accordance with future studies.
Indexed as
Identifiers
21170607What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.